The 3-year efficacy of Pegcetacoplan for geographic atrophy was studied in Ashkan M. Abbey, MD.

Published Date: 06 Jun 2024

Ashkan Abbey, MD discusses the GALE extension trial, which involved three years of pegcetacoplan treatment, and pivotal data from the OAKS and DERBY trials at ARVO 2024.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

2.

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

3.

In prostate cancer survivorship, sleep disturbances are underappreciated.

4.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

5.

a cutting-edge cancer diagnostic tool.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot